Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text Services Email this article Alert me to new content in the JEM Citing Articles Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20061104
Serafini et al.

• Figure S1 PDE-5 inhibitors reduce tumor growth, but persistent tumors show evidence of immune editing.

• Figure S2 The antitumor effect of sildenafil is maintained even with delayed treatment.

• Figure S3 Sildenafil increases CD8⁺ TILs.

• Figure S4 Sildenafil fails to induce an antitumor effect in 4T1-HA-bearing Rag-2^-/- mice.

• Figure S5 Sildenafil fails to augment proliferation of purified T cells.

• Figure S6 Sildenafil does not alter IL-13 or IFN-γ production from CD11b⁺ cell.

This Article Abstract Full Text Services Email this article Alert me to new content in the JEM Citing Articles Citing Articles via CrossRef